Merimsky O - Search Results

1

Efficacy and safety of first-line erlotinib in elderly patients with advanced non-small cell lung cancer.

Merimsky O, Cheng CK, Au JS, von Pawel J, Reck M. Merimsky O, et al. Oncol Rep. 2012 Aug;28(2):721-7. doi: 10.3892/or.2012.1824. Epub 2012 May 18. Oncol Rep. 2012. PMID: 22614912 Clinical Trial.

2

The use of interferon alpha-C in patients with metastatic renal cell carcinoma arising in a congenital solitary kidney.

Merimsky O, Merimsky E, Chaitchik S. Merimsky O, et al. Among authors: merimsky e. J Surg Oncol. 1990 Dec;45(4):279-81. doi: 10.1002/jso.2930450413. J Surg Oncol. 1990. PMID: 2250479

3

Prognostic importance of advanced age in aggressive non-Hodgkin's malignant lymphoma.

Kovner F, Merimsky O, Inbar M, Soyfer V, Cahan Y, Rachmani R, Chaitchik S. Kovner F, et al. Among authors: merimsky o. Oncology. 1996 Nov-Dec;53(6):435-40. doi: 10.1159/000227617. Oncology. 1996. PMID: 8960137

4

Vascular invasion in high grade sarcoma of the extremity is associated with short overall survival.

Merimsky O, Isakov J, Kollender Y, Nirkin A, Inbar M, Meller I. Merimsky O, et al. Oncol Rep. 1998 Jul-Aug;5(4):985-9. doi: 10.3892/or.5.4.985. Oncol Rep. 1998. PMID: 9625859

5

Adriamycin-ifosfamide induction chemotherapy for extremity soft tissue sarcoma: comparison of two non-randomized protocols.

Merimsky O, Meller I, Issakov J, Kollender Y, Oron D, Flusser G, Gutman M, Lev-Chelouche D, Inbar M. Merimsky O, et al. Oncol Rep. 1999 Jul-Aug;6(4):913-20. doi: 10.3892/or.6.4.913. Oncol Rep. 1999. PMID: 10373681 Clinical Trial.

6

Monthly gemcitabine (days 1, 8 and 15) plus cisplatin (days 1-3) in advanced non-small cell lung cancer: a phase II study.

Merimsky O, Wigler N, Greif Y, Schwartz Y, Asna N, Paz J, Mann A, Inbar M. Merimsky O, et al. Anticancer Drugs. 2000 Feb;11(2):117-21. doi: 10.1097/00001813-200002000-00008. Anticancer Drugs. 2000. PMID: 10789594 Clinical Trial.

7

Is forequarter amputation justified for palliation of intractable cancer symptoms?

Merimsky O, Kollender Y, Inbar M, Lev-Chelouche D, Gutman M, Issakov J, Mazeh D, Shabat S, Bickels J, Meller I. Merimsky O, et al. Oncology. 2001;60(1):55-9. doi: 10.1159/000055297. Oncology. 2001. PMID: 11150909

8

Correlation between c-erbB-4 receptor expression and response to gemcitabine-cisplatin chemotherapy in non-small-cell lung cancer.

Merimsky O, Staroselsky A, Inbar M, Schwartz Y, Wigler N, Mann A, Marmor S, Greif J. Merimsky O, et al. Ann Oncol. 2001 Aug;12(8):1127-31. doi: 10.1023/a:1011665216616. Ann Oncol. 2001. PMID: 11583195 Free article.

9

Sarcoma and thyroid disorders: a common etiology?

Merimsky O, Issakov J, Kollender Y, Inbar M, Bickels J, Meller I. Merimsky O, et al. Oncol Rep. 2002 Jul-Aug;9(4):863-9. Oncol Rep. 2002. PMID: 12066223

10

Induction chemotherapy for bone sarcoma in adults: correlation of results with erbB-4 expression.

Merimsky O, Kollender Y, Issakov J, Inbar M, Flusser G, Benayahu D, Meller I, Bickels J. Merimsky O, et al. Oncol Rep. 2003 Sep-Oct;10(5):1593-9. Oncol Rep. 2003. PMID: 12883746

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

228 results

Search Page

Filters